Navigation Links
GeneCards® Version 3.07 Released
Date:11/14/2011

the Crown Human Genome Center, and the incumbent of the Ralph & Lois Silver Professorial Chair of Human Genomics at the Weizmann Institute of Science.

About Xennex  

Founded in 2003, Xennex, Inc. (www.xennexinc.com) is a dynamic privately held company that is dedicated to providing Biotechnology, Pharmaceutical and other life sciences companies, as well as organizations dealing with biotechnology intellectual property, the highest level of services and tools to enhance their gene-based research. Xennex's products help such organizations to optimize their efforts to develop innovative medical products and services.

Xennex's customers include many of the world's leading biotech and pharmaceutical companies and organizations dealing with intellectual property, located in North America, Europe and Japan. Xennex's products are used in hundreds of commercial and academic organizations by tens of thousands of users around the globe.

For further information, please contact:

Xennex Inc.
Kenneth Elsner
Director of US operations and CFO
Tel: +1 781 826 7719 (USA)
kelsner@xennexinc.com

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.


'/>"/>
SOURCE Xennex Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Perrigo Announces Launch of Generic Version of Elestat®
2. Mylan Receives Approval for Generic Version of MS Contin® Tablets
3. Mylan Launches First Generic Version of Exelon® Capsules in the U.K.
4. Watson Provides Update on District Court Order Concerning Generic Version of LOVENOX®
5. Watson Confirms District Court Order Concerning Generic Version of LOVENOX(R)
6. Sysmex Announces Newest Version of Clinical Laboratory Management Software
7. Mylans Matrix Receives Tentative FDA Approval Through PEPFAR for Novel "Co-Packaged" Version of HIV/AIDS Treatment
8. PDL BioPharma Announces Conversion Rate Adjustments for Its Convertible Notes
9. Medicomp Releases ICD-10-CM with New Version of the Powerful MEDCIN Engine®
10. Mylan Launches Generic Version of Uroxatral® Tablets
11. Hospira Announces U.S. Approval of Solution Version of Gemcitabine Injection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 28, 2015 Research and Markets ... Jain PharmaBiotech,s new report "Cardiovascular Drug Delivery ... offering. Drug delivery to the cardiovascular ... because of the anatomy and physiology of the ... all organs of the body. Drugs can be ...
(Date:5/29/2015)... and BOSTON , May ... in instrument development, custom automation, and contract manufacturing, and ... the Nanopatch™ needle-free drug delivery technology, have been named ... of the Nanopatch Jet Coating Instrument , an ... research and product development.  The award was announced last ...
(Date:5/29/2015)... and MENLO PARK, Calif. ... Pharmaceuticals, Inc. (OTCQX: DMPI) ("DelMar" and the ... commercializing proven cancer therapies in new orphan drug ... American Association of Cancer Research (AACR) Advances in ... for its lead product candidate VAL-083 ...
Breaking Medicine Technology:Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... VILLAGE, Nev., Nov. 2 PDL BioPharma, Inc. (PDL) ... on its previously disclosed $300 million securitization transaction intended ... royalties. Morgan Stanley & Co. Incorporated acted as ... terms of the securitization transaction, PDL sold to QHP ...
... Nov. 2 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced ... 30, 2009 on Monday, November 9, 2009, following the close of ... conference call at 5:00 p.m. Eastern Time on the same day ... call will be available for two weeks following the event. ...
Cached Medicine Technology:PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction 2Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009 2Alexza to Announce 2009 Third Quarter Financial Results and Update Its AZ-004 NDA Status on Monday, November 9, 2009 3
(Date:5/30/2015)... 2015 This year the National ... Horizons to offer one of the most diverse perspectives ... successful practices to diagnose, treat and manage patients with ... Horizons Conference is Interaction with Multidisciplinary Healthcare Professionals ... Needs of Patients with COPD," said Brian W. Carlin, ...
(Date:5/30/2015)... (PRWEB) May 30, 2015 Venus Viva ... acne scars, large pores, deep wrinkles, stretch marks, pigmentation ... medical professional, such as Dr. F. Victor Rueckl of ... the clinical trials in Las Vegas. This body image ... into a system that delivers proven results through a ...
(Date:5/29/2015)... “In the current environment of ... regulations, we provide education that will help practitioners ... suffering from pain, within the boundaries of the ... of rehabilitation medicine and President/Medical Director of the ... , A new flight of PAINWeekEnd Regional Conferences ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 What does ... The Denver Foundation, community comes together to plant gardens, ... build neighborhoods and awareness of critical issues. Community invites ... Denver and beyond. , "What Community Does" was commissioned ... foundation in Colorado, and released during the foundation’s Annual ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The third ... The event, now closed to new registration, starts outside ... This exciting competitive running event demonstrates the power ... create a public benefit – in this case, historic ... views around the famed Ocean Drive and passes by ...
Breaking Medicine News(10 mins):Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 2Health News:Pulmonary Horizons 2nd Annual COPD Conference Miami Hilton Downtown, July 17-19, 2015 Patient Centered Cross-Continuum Education to Improve the Care of Patients with COPD 3Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 2Health News:Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva. 3Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:What Community Does: A New Video from The Denver Foundation 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3
... who had "Tommy John" elbow reconstruction surgery were able to ... to a study released today at the 2008 American Orthopaedic ... Grande Lakes. While reassuring to athletes, the study authors find ... surgery, alarming. , "Before 1997 this surgery was performed on ...
... (CDH) of Winfield, Ill. has been ranked #47 in ... accessible today online,at http://www.usnews.com/besthospitals and on sale ... 5,453 hospitals reviewed, only 170 medical centers,nationwide ranked high ... listed in one or more of the 16 specialties., ...
... 11 In a letter to the,Senate, forty-five ... to address critical shortfalls in legislation that would,reauthorize ... the Senate,poised to vote on a five-year, $50 ... to "both set and correct policies based,on evidence ...
... Calif., July 11 A,democratic process involving several SEIU ... with hearings to determine the best way to unite,long-term ... greatest strength,to win for their families and the clients ... a thorough, open, and democratic,discussion to make sure that ...
... no difference, study finds , , FRIDAY, July 11 (HealthDay ... developing breast cancer do not seem to improve even ... the disease, a new report says. , Scientists have ... small but statistically significant increase in the risk of ...
... Zen at Zoe's Garden, a new Baltimore wellness center offering massage ... in Fells Point. , ... Baltimore, MD (PRWEB) July ... wellness center offering massage therapy, acupuncture, yoga instruction , ...
Cached Medicine News:Health News:Dramatic increase in 'Tommy John' surgery in young patients cause for concern 2Health News:Central DuPage Hospital's Orthopedics Ranks in U.S. News Media Group's 2008 Edition of America's Best Hospitals for the Second Consecutive Year 2Health News:Central DuPage Hospital's Orthopedics Ranks in U.S. News Media Group's 2008 Edition of America's Best Hospitals for the Second Consecutive Year 3Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 2Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 3Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 4Health News:Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding 5Health News:Recent Genetic Discoveries Don't Improve Prediction of Breast Cancer 2Health News:Baltimore Wellness Center "Zen at Zoe's Garden" Launches in Baltimore's Fells Point 2
Spurling-Kerrison (Colclough) Laminectomie Rongeur. 15 cm - 6, thick footplate, large handle, 40 up-cutting, jaws 3 mm wide....
Kerrison (Micro) Laminectomie Rongeur, with ejector. 18 cm - 7 1/8, with thick footplate, small handle, 90 up-cutting, jaws 2 mm wide....
... The Tangent Posterior Impacted Instrument Set offers ... of the advantages offered by the Tangent ... preparation and the ability to reproduce the ... to ensure proper vertebral body distraction. A ...
Regulates physiological flow within normal ranges of Intraventricular Pressure (IVP) in the supine, sitting or standing position....
Medicine Products: